Clinical trial
Correlation of Serum Adalimumab Levels at an Administration of 40 mg Weekly vs 80 mg Every Two Weeks
NCT04404517 is registered in ClinicalTrials.gov with Hospital Universitario La Paz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Correlation of Serum Adalimumab Levels at an Administration of 40 mg Weekly vs 80 mg Every Two Weeks
- Lead sponsor
- Hospital Universitario La Paz
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 1, 2019
- Completion date
- October 30, 2021
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.